Pharm prime vendor fleet
Ended Awarded
- Contract number
- SPE2DU26F0C86
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,230
Award facts
- Contract value 100% obligated
- $22,230.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $22,230 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, requires no set-aside designation, indicating the contractor won through open competition. DMS Pharmaceutical Group will deliver pharmaceutical products and medical consumables to support federal healthcare operations, drawing from its extensive portfolio that includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical supplies.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy. The IDC, designated SPE2DR and awarded on November 13, 2025, establishes a $500 million ceiling with a completion date of December 31, 2036, enabling the contractor to serve as a regional prime vendor for the Department of Defense's pharmaceutical supply needs globally. This contract structure allows DLA to issue ongoing firm fixed-price delivery orders for routine and specialized pharmaceutical requirements across military healthcare facilities, leveraging DMS Pharmaceutical Group's established performance and capability to fulfill diverse medical supply demands.
Quick answers
Who was awarded contract SPE2DU26F0C86?
SPE2DU26F0C86 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DU26F0C86 worth?
The government has obligated $22,230 on SPE2DU26F0C86.
Is contract SPE2DU26F0C86 an order under another contract?
Yes. SPE2DU26F0C86 is a delivery order under SPE2DU25D9809, an indefinite delivery contract.
Was contract SPE2DU26F0C86 competed?
The extent of competition for SPE2DU26F0C86 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award